Jazz Pharmaceuticals (JAZZ) Cash from Operations Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.94 Bn | 934.80 Mn | -5.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.03% |
| Dec 31, 2025 | -9.05% |
| Sep 30, 2025 | 19.03% |
| Jun 30, 2025 | -73.19% |
| Mar 31, 2025 | 60.84% |
| Dec 31, 2024 | 138.19% |
| Sep 30, 2024 | 29.80% |
| Jun 30, 2024 | 11.65% |
| Mar 31, 2024 | -16.68% |
| Dec 31, 2023 | -51.07% |
| Sep 30, 2023 | -26.51% |
| Jun 30, 2023 | -2.07% |
| Mar 31, 2023 | 53.46% |
| Dec 31, 2022 | 92.38% |
| Sep 30, 2022 | 52.52% |
| Jun 30, 2022 | 626.79% |
| Mar 31, 2022 | -26.67% |
| Dec 31, 2021 | -4.57% |
| Sep 30, 2021 | 6.27% |
| Jun 30, 2021 | -77.16% |